To review the recent literature on risk factors for chronic rhinosinusitis (CRS) with an emphasis on genetic, comorbid diseases and environmental factors associated with CRS. Through identifying potential risk factors for CRS, we aim to glean insights into the underlying pathogenic mechanisms essential for developing effective therapeutic strategies.
INTRODUCTION
Chronic rhinosinusitis (CRS) is defined as a symptomatic inflammation of the sinonasal mucosa that persists for at least 12 weeks and is one of the most common chronic diseases of adults in the United States [1] [2] [3] . CRS is typically classified clinically into two distinguishable phenotypes: CRS without nasal polyposis (CRSsNP) and CRS with nasal polyposis (CRSwNP). CRS is estimated to affect about 13% of the population in the United States [4] and 10.9% of the population in Europe with an incidence of 1.13 per 100 person-years [5, 6 && ]. Patients with CRS suffer from significantly impaired quality of life, including decreased health utility, emotional distress, and decreased physical and social activity, with disease-specific expenditures totaling approximately $6 billion annually [7] [8] [9] [10] [11] .
Although the pathogenesis of CRS has been under active investigation, the cause of CRS still remains controversial [12] . CRSsNP has traditionally been considered a consequence of bacterial infection similar to acute rhinosinusitis, whereas CRSwNP is most frequently characterized by type 2 inflammation in western populations. Other potential risk factors for both forms of CRS have included anatomical obstruction of the osteomeatal complex, impaired mucociliary clearance, osteitis, microbes, biofilms, superantigen effects, immune dysfunctions, impaired epithelial defense, genetic factors, and environmental exposures such as inhaled allergens and irritants ( Fig. 1) [1, 2, 13, 14] .
Given the significant health and economic impact, and the lack of widely accepted representative animal models to study CRS mechanistically, understanding risk factors for CRS might provide insights into the underlying pathogenic mechanisms and may facilitate preventive interventions that mitigate risk factors to reduce progression to CRS. This review will briefly summarize the recent ] performed a comprehensive and current review of the literature examining the genetics of CRS; in this section, we will briefly summarize her major findings and highlight pertinent emerging literature published in the interim. As pointed out in her excellent review, interpretation of genetic studies in CRS has been limited by the resolution to which CRS patients were phenotyped, over-representation of CRS patients undergoing sinus surgery, sparse replication studies, differences in study design that preclude comparison with other meta analyses, and inadequate accounting for linkage disequilibrium and multiple testing. Nonetheless, genes found to significantly associate with CRS can broadly be categorized into genes involved with ion channels (e.g. CFTR); genes encoding human leukocyte antigens (e.g. HLA-A, HLA-B, HLA-C, HA-DR, and HLA-DQ); genes involved in innate immunity (e.g. CD14, IRAK4, LFT, MET, NOS1, NOS1AP, NOS2A, SERPINA1, and TLR2); genes involved in type 2 inflammation (e.g. IL1RL1, IL4, IL13, and IL33); genes involved in inflammation (e.g. IDO1, IL1A, IL1B, IL1R2, IL1RN, IL6, IL22RA1, LTA, TNF, and TNFA1P3); genes involved in tissue remodeling (e.g. MMP9, POSTN, and TGFB1); genes involved in arachidonic acid metabolism (e.g. LTC4S, PTGDR, and PTGS2); and others (e.g. ADRB2, AOAH, CACNA1I, DCBLD2, EMID2, GSTT1, KIAA1456, LAMA2, LAMB1, MSRA, MUSK, NAV3, PARS2, PTGS2, RYBP, TP73, and TRIP12). In Table 1 Rhinitis, sinusitis and upper airway disease CFTR, there were no replication studies validating these prior findings and no mechanistic studies demonstrating their biological relevance.
Recently, Henmyr et al. [38 & ] conducted a study of single-nucleotide polymorphisms (SNPs) previously implicated in either CRSwNP or CRSsNP using DNA from 613 patients with CRS and 1588 publicly available controls. They found significant (P < 0.05) associations between genetic variations in only seven genes (e.g. PARS2, TGFB1, NOS1, NOS1AP, IL22RA1, DCBLD2, and ALOX5AP) of the 53 SNPs examined. Of these, only the association between the rs2873551 SNP in the PARS2 gene was significant after a Bonferroni correction. PARS2 is a mitochondrial prolyl t-RNA synthase for which limited research exists; further validation of these genetic association studies and research on the function of PARS2 gene may shed light on reasons for its association with CRS. In the analysis comparing CRSwNP against the CRSsNP patient populations, the authors also found the rs4504543 SNP in the acyloxyacyl hydrolase (AOAH) gene was associated with the CRSwNP phenotype (P ¼ 0.022). This SNP had previously been associated with CRS in a pooling-based genome-wide association study (pGWAS) and replicated in a Chinese population with CRS [35, 39] .
Another emerging line of research suggests that polymorphisms in the bitter taste receptor T2R38 gene may also be associated with CRS status. In human sinonasal epithelial cells, microbial secretions activate the T2R38 receptor that regulates calcium flux-dependent nitric oxide production, stimulates mucociliary clearance, and increases direct antibacterial effects. The activity of these innate immune responses is dependent on three common polymorphisms, and the polymorphisms segregate together to form two common haplotypes of the TAS2R38 gene [40] . The functional prolinealanine-valine (PAV) haplotype combines with the nonfunctional alanine-valine-isoleucine (AVI) haplotype to generate three genotypes -PAV/ PAV, PAV/AVI, and AVI/AVI with the AVI/AVI genotype showing significantly impaired Pseudomonas aeruginosa killing in in-vitro cultured epithelial cells. More recently, Adappa et al. [41] examined the relative frequency of the AVI/AVI genotype and PAV/PAV genotypes in medically recalcitrant CRS patients compared with a geographically matched control population, and found a significantly higher rate of AVI/AVI genotype patients among the medically recalcitrant CRS group (P ¼ 0.0383), suggesting that the PAV/PAV genotype may decrease CRS risk. Separately, Mfuna Endam et al. [42] used a pGWAS and demonstrated SNPs associated with the TAS2R38 gene were found at a higher frequency in the CRS population compared with controls, although statistics and ORs were not reported. In other lines of research, Purkey et al. [43] examined the association between selected potassium channels and CRS status in a study comparing 828 children with CRS against 5083 controls, and found that two epithelial potassium channels KCNMA1 and KCNQ5 were associated with CRS status in Caucasian and African American children, respectively. This line of research, together with the TAS2R38 findings, and known associations with CFTR suggest that genes regulating ion flux in epithelial cells may confer significant genetic predisposition to CRS.
COMORBID DISEASES AND CONDITIONS ASSOCIATED WITH CHRONIC RHINOSINUSITIS
In addition to genes specifically associated with CRS, it has been recognized that CRS is associated with specific comorbid medical conditions that directly affect the airway. Other studies also suggest gastroesophageal reflux disease (GERD) and autoimmune/inflammatory diseases, and various demographic factors may similarly be associated with having CRS. These factors have been recently reviewed by Lam et al. in a recently published review article, but are further summarized in our discussion and in Table 2 ]. This study was able to reveal patterns of care and diagnoses prior to receiving a CRS diagnosis and contrasts from prior studies that have used specialty care populations with more treatment refractory severe disease, or have used only assessments without information regarding the temporal relationships of diagnosis. In this study, allergic rhinitis was specifically found to have a significant association with CRS [adjusted OR (aOR) 2.4 and 2.6 for CRSsNP and CRSwNP, respectively]. Although high (30-80%) rates of atopic sensitization among CRS patients have long been reported, few studies have compared these results against those of the general population, even though rates of atopic sensitization in the general population have been reported as high as 40-55% [48, 49] . Furthermore, there are significant differences in the threshold for atopic testing among the various published studies of atopy amongst CRS patients. In our own studies, we found higher rates of multiple sensitization among tested patients with CRSwNP compared with a control population of patients with rhinitis symptoms [50] . Other larger population-based studies [5, 45] have found strong associations between allergic rhinitis and comorbid CRS, although the timing of the allergic rhinitis diagnosis relative to CRS onset was not elucidated ( Table 2 ). In the study by Kim et al., the aOR of having CRS among patients with moderate-tosevere persistent allergic rhinitis was 8.2 when compared with mild intermittent allergic rhinitis. One limitation of epidemiologic studies of allergic rhinitis and CRS is that the symptoms of these two conditions overlap substantially and may be difficult to differentiate using a questionnaire. In contrast to these data other studies [51] [52] [53] do not find that allergic rhinitis status affects management of CRS, need for surgical intervention, or correlations with clinical symptom or radiographic severity. Thus, while a history of atopic sensitization is more common among patients with CRS, its effect on CRS severity and treatment response rates remains unclear.
Similarly to allergic rhinitis, asthma is strongly associated with CRS status, especially CRSwNP ( Table 2 ). In the GHS study, the aOR of having an asthma diagnosis preceding the incident CRSwNP diagnosis was 2.8 and 1.7 for CRSsNP compared with control patients without an incident CRS diagnosis, and was further increased to 4.4 and [54, 55] do demonstrate that asthma severity may correlate with radiographic CRS severity and that the frequency and severity of CRS may affect the severity of coexistent asthma. In some patients, CRSwNP, asthma, and aspirin sensitivity form a well established association known as aspirin-exacerbated respiratory disease (AERD) or Samter's triad. Following exposure to aspirin, patients with AERD presumably overproduce cysteinyl leukotrienes and prostaglandin D 2 that are mediators of eosinophilic inflammation and down-regulate anti-inflammatory prostaglandin E 2 [16, 56] .
In addition to asthma and allergic rhinitis, the GHS study also revealed a pattern of episodic and chronic lower airway illnesses preceding the diagnosis of CRS and supported the hypothesis of the unified airway. Interestingly, premorbid bronchitis and pneumonia were significantly more common in patients who developed CRS. These findings suggest that acute episodic respiratory diseases may modify host susceptibility to CRS, perhaps similarly to the relationship between rhinovirus and respiratory syncytial virus infections and subsequent asthma development [57, 58] . These findings have also been supported by the more recently published study [46 & ] utilizing the insurance claims-based LHID2000 dataset in which 'chronic pulmonary disease' was the second most strongly associated condition, after asthma, with otolaryngologist-diagnosed CRS (aOR 3.0, 95% CI 2.8-3.3).
GASTROESOPHAGEAL REFLUX DISEASE AND OTHER GASTROINTESTINAL DISEASES
Gastroesophageal reflux disease is known to play some roles in various diseases of the upper and lower airway diseases such as chronic cough [59] , asthma [55] , and otitis media with effusion, especially in young children [60] . There is some evidence to suggest an association between GERD and CRS [47, [60] [61] [62] [63] . For example, the GHS study showed a modest, but significant, relationship between GERD and CRS. The European Community Respiratory Health Study (ECRHS), which is a multinational longitudinal study, has similarly suggested that GERD, particularly the nocturnal subtype, is strongly associated with the development of lower respiratory tract diseases, such as asthma, but has not specifically examined its effect on rhinosinusitis [64] . Others have suggested that omeprazoleresponsiveness of sinusitis symptoms was indicative of a role for GERD in CRS pathogenesis [65] . However, intriguing research from the eosinophilic esophagitis literature suggests that omeprazole may be anti-inflammatory independently of its effects on suppressing acid production in gastric parietal cells [66] . It should be noted that eosinophilic esophagitis shares histologic, and immunopathologic, parallels with CRSwNP.
INFLAMMATORY AND AUTOIMMUNE DISEASES
Other premorbid disease associations with CRS include inflammatory and autoimmune diseases [46 & ,67-69] . In the GHS study, the association between lupus and CRS had an aOR of 3.6, although this was not statistically significant at the stringent level of P less than 0.0005 used in the study. These associations are remarkable given recent findings that local immune responses in CRSwNP seem to generate autoantibodies, particularly against nuclear and epithelial antigens [70, 71] . In a more recently published study, using the LHID2000 database from Taiwan, the investigators found significant comorbid associations between a rheumatoid arthritis diagnosis (aOR 1.85, 95% CI 1.63-2.1) and CRS, although the association between lupus and CRS was not statistically significant due to the relative rarity of lupus in the Taiwanese population. 74] . In both the LHID2000 study and the GHS study, the strength of co/premorbid associations between CRS and headache diagnoses was moderate, with aOR between 2.0 and 2.3. However, other lines of research suggest that whereas migraine affects CRS risk, it does not affect symptomatic improvement following treatment for CRS [75] .
OTHER COMORBIDITIES AND DEMOGRAPHIC FACTORS
Apart from comorbid disease, epidemiologic studies demonstrate underlying demographic factors that are associated with CRS. These studies demonstrated that the peak incidence of CRS among adults was between ages 45 and 54 years [6 && ], whereas others subsequently demonstrate that peak prevalence is between 50 and 59 [76] . Sex also had an effect of CRS phenotype with more women developing CRSsNP, whereas men were more likely to develop CRSwNP. The age of onset and sex predisposition for CRS phenotypes may provide a basis for future research to determine possible hormone or aging-specific effects on the pathogenesis of CRS.
ENVIRONMENTAL FACTORS ASSOCIATED WITH CHRONIC RHINOSINUSITIS
Environmental factors are known to have significant effects in the pathogenesis of various airway diseases as best illustrated in studies on asthma, tobacco exposure, and hypersensitivity pneumonitis. Since airway diseases are unified by the responses of airway epithelial cells and exposure to inhaled pollutants, allergens, irritants, and toxins, it is tempting to speculate that many of the environmental exposures linked to lower airway disease will be of relevance to CRS (Table 3 ).
TOBACCO EXPOSURE
Tobacco exposure is one of the best studied risk factors for various airway diseases, including CRS. There is some evidence that active cigarette smoking is more prevalent among patients with CRS [77] [78] [79] . The GA 2 LEN study [77] determined that there is a strong association between CRS and active tobacco use (aOR 1.9, 95% CI 1.8-2.1), with a significant, but weaker, association of CRS with former smokers (aOR 1.3, 95% CI 1.2-1.4). In the subset of GA 2 LEN patients from Denmark, Thilsing et al. [78] revealed that smoking status (non, former, or current smoker) significantly affected the CRS prevalence (P ¼ 0.000), while current smoking was associated with an increased CRS prevalence in women [relative risk (RR) ¼ 2.5], as well as men (RR ¼ 1.9), compared with nonsmokers. Separately, analysis of the third National Health and Nutrition Examination Survey (NHANES III) study found more modest associations between self-reported sinusitis and active smokers. Even at the highest exposure to more than 40 cigarettes per day, the adjusted RR for CRS was only approximately 1.20 [80] . Neither of these studies, however, specifically separated associations for CRSsNP and CRSwNP. The few studies examining the relationship between secondhand smoke exposure or environmental tobacco smoke (ETS) and adult CRS have produced conflicting results, while studies of CRS in children have demonstrated a consistent association between ETS and CRS among children who have had sinus surgery [79] [80] [81] [82] . Studies [83, 84] examining the pathophysiologic effects of tobacco smoke on sinonasal mucosa suggest the reported associations are biologically plausible given findings that smoke decreases the mucociliary clearance of sinonasal mucosa by altering ionic transport mechanisms, impairs ciliogenesis, and suppresses innate immunity through alterations in toll-like receptors (TLRs), effector proteins (e.g. b-defensins), and complement components.
OUTDOOR AND INDOOR AIR QUALITY
While patients and the lay media frequently ascribe sinusitis to air quality, there are surprisingly few previous studies that examine the relationship between air pollution and sinusitis, and fewer yet that use the commonly accepted diagnostic criteria for CRS. Min et al. [85] , in the first epidemiologic survey to determine CRS prevalence in South Korea, found no difference between rural and urban areas with regard to the prevalence of CRS. Wolf [86] analyzed the addresses of 1435 patients who sought treatment for CRS in a tertiary care hospital in Cologne, Germany, and correlated this against outdoor air quality measures that were collected through a program monitoring air quality in the Rhine and Ruhr area with 1 km 2 resolution. It was found that when air pollution levels were correlated against CRS patient rates, no correlation was found, but if analysis was restricted to the districts with above-average air pollution levels, a weak (adjusted R 2 ¼ 0.3), but significant, positive correlation was found between air pollution levels and CRS case rates [86] . The author acknowledged that only sulphur dioxide (SO 2 ), nitrogen dioxide (NO 2 ), and total suspended particulate matter were analyzed, only a convenience sample of patients was used, no information on individual outdoor exposure was collected, and there was no attempt to correlate air pollution levels with disease severity. Another study by Bhattacharyya [87] correlated national rates of self-reported sinusitis in the United States with average national ambient SO 2 , NO 2 , carbon monoxide, and particulate matter, and found significant, but weak, correlations in the prevalence of sinusitis with all air pollution parameters despite the lack of geographic resolution. Asian sand dust (ASD), originating in the arid deserts of Mongolia and China, brings large amounts of windborne soil particles to countries in the Asia-Pacific area and has been associated with inducing respiratory illness in the recent years [88] . ASD spreads over large areas of several countries, especially Korea, Japan, and China. To our knowledge, although no direct studies have examined the effects of ASD exposure and CRS status, Yeo et al. [89] showed that ASD directly increased rhinovirus replication and aggravated rhinovirus-induced inflammation in human nasal epithelial cells by enhancing interferon (IFN)-g, interleukin (IL)-1b, IL-6, and IL-8 secretion, providing a possible mechanism by which dust exposure, nasal microbiology, and the immunologic barrier may be intertwined. In addition to outdoor air pollution, the effects of indoor air pollution on respiratory disease can be substantial -in fact, studies suggest that indoor pollutant levels are substantially higher than outdoor pollutant levels and, further, do not intercorrelate. Studies in asthma suggest that indoor endotoxin; allergen exposure to mouse, cockroach, pets, dust mite, and mold, as well as indoor pollutants such as particulate matter and NO 2 levels have a significant effect on asthma morbidity [90] . Similarly, some volatile organic compounds (e.g. formaldehyde, benzene, toluene, and chlorobenzene), which are irritants, and indoor sources (e.g. solvents, floor adhesive, paint, cleaning products, furnishings, polishes, and room fresheners) have an effect on the development of asthma [91, 92] . To our knowledge, there has been only one study that focused on indoor environments and nasal polyps. Kim and Hanley [93] reported an association between the use of woodstoves as a principal source of heat and nasal polyposis. No study has examined the association between indoor pollutants and CRS without polyps, outside of occupational exposure studies.
Airborne particles and vapors in the occupational environment may play an important role in CRS risk, although studies of these exposures have used definitions that make it difficult to differentiate between CRS and conditions with similar symptoms, such as occupational rhinitis [94] . Thilsing et al. [78] , using the symptom-based definition of CRS, found that working in a blue collar job significantly increased the CRS prevalence in women, but conversely, adjusted risk was significantly lower among male blue collar compared with male white collar workers. Additionally, workplace exposure to 'gases, fumes, dust, or smoke' increased the crude risk of CRS, although adjusted RR did not reach statistical significance [78] . Further analysis of 14 specific exposures found that only working with 'fish or shellfish' was significantly associated with CRS status [78] . Other lines of work examining occupational rhinitis have also found significant associations between low-molecular-weight agent exposure, persulfate salts, latex, and animal exposure, and rhinosinusitis symptoms in specific occupations. However, none of these studies [95] [96] [97] [98] [99] utilized a clear definition of CRS or required objective evidence of inflammation, and thus, extrapolating these findings to CRS is difficult.
CONCLUSION
Risk factors associated with CRS include genetic and comorbid medical as well as environmental factors. From these insights, we glean insights into the pathophysiology of CRS and can conceptualize studies of novel therapeutic and preventive strategies to reduce the burden of CRS. However, most current study designs establish associations, but causality and dose-response cannot yet be established. Improvements in study design, particularly interventional studies or longitudinal cohort studies, and biological validation studies may provide estimates of the magnitude these risk factors have on disease severity and prevalence.
